{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:45:58Z","timestamp":1783338358187,"version":"3.54.6"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10495-020-01594-5","type":"journal-article","created":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T18:02:37Z","timestamp":1581184957000},"page":"261-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma"],"prefix":"10.1007","volume":"25","author":[{"given":"S. I.","family":"Omoruyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. E.","family":"Ekpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. M.","family":"Semenya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6975-5255","authenticated-orcid":false,"given":"S.","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,8]]},"reference":[{"key":"1594_CR1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clineuro.2017.05.021","volume":"159","author":"Y-J Lin","year":"2017","unstructured":"Lin Y-J, Chiu H-Y, Chiou M-J, Huang Y-C, Wei K-C, Kuo C-F, Hsu J-T, Chen P-Y (2017) Trends in the incidence of primary malignant brain tumors in Taiwan and correlation with comorbidities: a population-based study. Clin Neurol Neurosurg 159:72\u201382","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"1594_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97\u2013109","journal-title":"Acta Neuropathol"},{"issue":"5","key":"1594_CR3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","volume":"359","author":"PY Wen","year":"2008","unstructured":"Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492\u2013507","journal-title":"N Engl J Med"},{"key":"1594_CR4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-60327-492-0_14","volume":"25","author":"H Ohgaki","year":"2009","unstructured":"Ohgaki H (2009) Epidemiology of brain tumors. Cancer Epidemiol 25:323\u2013342","journal-title":"Epidemiology of brain tumors. Cancer Epidemiol"},{"issue":"21","key":"1594_CR5","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1200\/JCO.2017.74.2965","volume":"35","author":"IK Mellinghoff","year":"2017","unstructured":"Mellinghoff IK, Gilbertson RJ (2017) Brain tumors: challenges and opportunities to cure. J Clin Oncol 35(21):2343\u20132345","journal-title":"J Clin Oncol"},{"issue":"2","key":"1594_CR6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/exnr.1996.0156","volume":"141","author":"PJ Elliott","year":"1996","unstructured":"Elliott PJ, Hayward NJ, Huff MR, Nagle TL, Black KL, Bartus RT (1996) Unlocking the blood\u2013brain barrier: a role for RMP-7 in brain tumor therapy. Exp Neurol 141(2):214\u2013224","journal-title":"Exp Neurol"},{"issue":"8","key":"1594_CR7","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.2003.05.063","volume":"21","author":"A Giese","year":"2003","unstructured":"Giese A, Bjerkvig R, Berens M, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21(8):1624\u20131636","journal-title":"J Clin Oncol"},{"issue":"1","key":"1594_CR8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2741\/Smith","volume":"5","author":"JS Smith","year":"2000","unstructured":"Smith JS, Jenkins RB (2000) Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 5(1):213\u2013231","journal-title":"Front Biosci"},{"issue":"10","key":"1594_CR9","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/brain\/awm204","volume":"130","author":"D Krex","year":"2007","unstructured":"Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G (2007) Long-term survival with glioblastoma multiforme. Brain 130(10):2596\u20132606","journal-title":"Brain"},{"issue":"3\u20134","key":"1594_CR10","first-page":"61","volume":"8","author":"TI Oprea","year":"2011","unstructured":"Oprea TI, Bauman JE, Bologa CG, Buranda T, Chigaev A, Edwards BS, Jarvik JW, Gresham HD, Haynes MK, Hjelle B (2011) Drug repurposing from an academic perspective. Drug Discov Today 8(3\u20134):61\u201369","journal-title":"Drug Discov Today"},{"issue":"8","key":"1594_CR11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3(8):673","journal-title":"Nat Rev Drug Discov"},{"key":"1594_CR12","volume-title":"Bioactive molecules: phenothiazine and 1, 4-benzothiazines, Chemical and Biological Aspects","author":"R Gupta","year":"1988","unstructured":"Gupta R (1988) Bioactive molecules: phenothiazine and 1, 4-benzothiazines, Chemical and Biological Aspects, vol 4. Elsevier, Amsterdam"},{"issue":"5","key":"1594_CR13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ardp.200900253","volume":"343","author":"B Morak-M\u0142odawska","year":"2010","unstructured":"Morak-M\u0142odawska B, Pluta K, Matralis AN, Kourounakis AP (2010) Antioxidant Activity of Newly Synthesized 2, 7-Diazaphenothiazines. Arch Pharm 343(5):268\u2013273","journal-title":"Arch Pharm"},{"issue":"9","key":"1594_CR14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10495-012-0717-2","volume":"17","author":"S Kang","year":"2012","unstructured":"Kang S, Dong SM, Kim B-R, Park MS, Trink B, Byun H-J, Rho SB (2012) Thioridazine induces apoptosis by targeting the PI3K\/Akt\/mTOR pathway in cervical and endometrial cancer cells. Apoptosis 17(9):989\u2013997","journal-title":"Apoptosis"},{"issue":"5","key":"1594_CR15","doi-asserted-by":"crossref","first-page":"e1753","DOI":"10.1038\/cddis.2015.77","volume":"6","author":"H-W Cheng","year":"2015","unstructured":"Cheng H-W, Liang Y-H, Kuo Y-L, Chuu C-P, Lin C-Y, Lee M-H, Wu AT, Yeh C-T, Chen EI, Whang-Peng J (2015) Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data. Cell Death Dis 6(5):e1753","journal-title":"Cell Death Dis"},{"issue":"6","key":"1594_CR16","first-page":"8171","volume":"14","author":"M Yong","year":"2017","unstructured":"Yong M, Yu T, Tian S, Liu S, Xu J, Hu J, Hu L (2017) DR2 blocker thioridazine: A promising drug for ovarian cancer therapy. Oncol Lett 14(6):8171\u20138177","journal-title":"Oncol Lett"},{"key":"1594_CR17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.biopha.2018.06.123","volume":"106","author":"M Seervi","year":"2018","unstructured":"Seervi M, Rani A, Sharma AK, Santhosh Kumar TR (2018) ROS mediated ER stress induces Bax-Bak dependent and independent apoptosis in response to Thioridazine. Biomed Pharmacother 106:200\u2013209","journal-title":"Biomed Pharmacother"},{"key":"1594_CR18","doi-asserted-by":"crossref","first-page":"27540","DOI":"10.1038\/srep27540","volume":"6","author":"C-H Wu","year":"2016","unstructured":"Wu C-H, Bai L-Y, Tsai M-H, Chu P-C, Chiu C-F, Chen MY, Chiu S-J, Chiang J-H, Weng J-R (2016) Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents\u2013a drug repurposing strategy. Sci Rep 6:27540","journal-title":"Sci Rep"},{"issue":"7","key":"1594_CR19","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3390\/ijms18071365","volume":"18","author":"B Brem","year":"2017","unstructured":"Brem B, Gal E, G\u0103in\u0103 L, Silaghi-Dumitrescu L, Fischer-Fodor E, Tomuleasa CI, Grozav A, Zaharia V, Filip L, Cristea C (2017) Novel thiazolo [5, 4-b] phenothiazine derivatives: synthesis, structural characterization, and in vitro evaluation of antiproliferative activity against human leukaemia. Int J Mol Sci 18(7):1365","journal-title":"Int J Mol Sci"},{"key":"1594_CR20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejmech.2017.04.028","volume":"134","author":"MM Ghorab","year":"2017","unstructured":"Ghorab MM, Alsaid MS, Samir N, Abdel-Latif GA, Soliman AM, Ragab FA, El Ella DAA (2017) Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules. Eur J Med Chem 134:304\u2013315","journal-title":"Eur J Med Chem"},{"issue":"12","key":"1594_CR21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3184\/174751917X15122516000140","volume":"41","author":"X-H Ma","year":"2017","unstructured":"Ma X-H, Liu N, Lu J-L, Zhao J, Zhang X-J (2017) Design, synthesis and antiproliferative activity of novel phenothiazine-1, 2, 3-triazole analogues. J Chem Res 41(12):696\u2013698","journal-title":"J Chem Res"},{"key":"1594_CR22","unstructured":"Dillon CP, Green DR (2016) Molecular cell biology of apoptosis and necroptosis in cancer. In: Apoptosis in cancer pathogenesis and anti-cancer therapy. Springer, New York, pp 1\u201323"},{"issue":"2","key":"1594_CR23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1(2):112","journal-title":"Nat Chem Biol"},{"issue":"1","key":"1594_CR24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong RS (2011) Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 30(1):87","journal-title":"J Exp Clin Cancer Res"},{"key":"1594_CR25","doi-asserted-by":"crossref","unstructured":"Hongmei Z (2012) Extrinsic and intrinsic apoptosis signal pathway review. In: Apoptosis and Medicine. Intech","DOI":"10.5772\/50129"},{"key":"1594_CR26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.nutr.27.061406.093749","volume":"27","author":"N Mizushima","year":"2007","unstructured":"Mizushima N, Klionsky DJ (2007) Protein turnover via autophagy: implications for metabolism. Annu Rev Nutr 27:19\u201340","journal-title":"Annu Rev Nutr"},{"key":"1594_CR27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-biochem-060815-014556","volume":"85","author":"CF Bento","year":"2016","unstructured":"Bento CF, Renna M, Ghislat G, Puri C, Ashkenazi A, Vicinanza M, Menzies FM, Rubinsztein DC (2016) Mammalian autophagy: how does it work? Annu Rev Biochem 85:685\u2013713","journal-title":"Annu Rev Biochem"},{"issue":"5","key":"1594_CR28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s10495-018-1456-9","volume":"23","author":"S-Y Cheng","year":"2018","unstructured":"Cheng S-Y, Chen N-F, Kuo H-M, Yang S-N, Sung C-S, Sung P-J, Wen Z-H, Chen W-F (2018) Prodigiosin stimulates endoplasmic reticulum stress and induces autophagic cell death in glioblastoma cells. Apoptosis 23(5):314\u2013328","journal-title":"Apoptosis"},{"issue":"1","key":"1594_CR29","first-page":"67","volume":"496","author":"B Wu","year":"2018","unstructured":"Wu B, Tan M, Cai W, Wang B, He P, Zhang X (2018) Arsenic trioxide induces autophagic cell death in osteosarcoma cells via the ROS-TFEB signaling pathway. Biochem Biophys Res Commun 496(1):67\u2013175","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"1594_CR30","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1002\/jcb.26808","volume":"119","author":"Y Ni","year":"2018","unstructured":"Ni Y, Wu S, Wang X, Zhu G, Chen X, Ding Y, Jiang W (2018) Cucurbitacin I induces pro-death autophagy in A549 cells via the ERK-mTOR-STAT3 signaling pathway. J Cell Biochem 119(7):6104\u20136112","journal-title":"J Cell Biochem"},{"issue":"2","key":"1594_CR31","doi-asserted-by":"crossref","first-page":"e57236","DOI":"10.1371\/journal.pone.0057236","volume":"8","author":"B Del Bello","year":"2013","unstructured":"Del Bello B, Toscano M, Moretti D, Maellaro E (2013) Cisplatin-induced apoptosis inhibits autophagy, which acts as a pro-survival mechanism in human melanoma cells. PLoS ONE 8(2):e57236","journal-title":"PLoS ONE"},{"issue":"3","key":"1594_CR32","doi-asserted-by":"crossref","first-page":"e92444","DOI":"10.1371\/journal.pone.0092444","volume":"9","author":"C Guzm\u00e1n","year":"2014","unstructured":"Guzm\u00e1n C, Bagga M, Kaur A, Westermarck J, Abankwa D (2014) Colonyarea: an imagej plugin to automatically quantify colony formation in clonogenic assays. PLoS ONE 9(3):e92444","journal-title":"PLoS ONE"},{"issue":"5","key":"1594_CR33","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NA Franken","year":"2006","unstructured":"Franken NA, Rodermond HM, Stap J, Haveman J, Van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1(5):2315","journal-title":"Nat Protoc"},{"issue":"4","key":"1594_CR34","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cam4.219","volume":"3","author":"A Torsvik","year":"2014","unstructured":"Torsvik A, Stieber D, Enger P\u00d8, Golebiewska A, Molven A, Svendsen A, Westermark B, Niclou SP, Olsen TK, Chekenya Enger M (2014) U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells. Cancer Med 3(4):812\u2013824","journal-title":"Cancer Med"},{"issue":"2","key":"1594_CR35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.mrgentox.2007.05.011","volume":"633","author":"S Gangopadhyay","year":"2007","unstructured":"Gangopadhyay S, Karmakar P, Dasgupta U, Chakraborty A (2007) Trifluoperazine stimulates ionizing radiation induced cell killing through inhibition of DNA repair. Mutat Res Genet Toxicol Environ Mutagen 633(2):117\u2013125","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"issue":"7","key":"1594_CR36","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1038\/cddis.2011.62","volume":"2","author":"D Zong","year":"2011","unstructured":"Zong D, H\u00e5\u00e5g P, Yakymovych I, Lewensohn R, Viktorsson K (2011) Chemosensitization by phenothiazines in human lung cancer cells: impaired resolution of \u03b3H2AX and increased oxidative stress elicit apoptosis associated with lysosomal expansion and intense vacuolation. Cell Death Dis 2(7):e181","journal-title":"Cell Death Dis"},{"issue":"10","key":"1594_CR37","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"EP Rogakou","year":"1998","unstructured":"Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273(10):5858\u20135868","journal-title":"J Biol Chem"},{"issue":"24","key":"1594_CR38","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.4161\/cc.5.24.3569","volume":"5","author":"OA Martin","year":"2006","unstructured":"Martin OA, Bonner WM (2006) \u03b3-H2AX in cancer cells: a potential biomarker for cancer diagnostics, prediction and recurrence. Cell Cycle 5(24):2909\u20132913","journal-title":"Cell Cycle"},{"issue":"5","key":"1594_CR39","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/nar\/gkn1085","volume":"37","author":"M Br\u00e1zdov\u00e1","year":"2009","unstructured":"Br\u00e1zdov\u00e1 M, Quante T, T\u00f6gel L, Walter K, Loscher C, Tich\u00fd V, \u010cin\u010d\u00e1rov\u00e1 L, Deppert W, Tolstonog GV (2009) Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences. Nucleic Acids Res 37(5):1486\u20131500","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1594_CR40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.arcmed.2010.02.007","volume":"41","author":"S Luan","year":"2010","unstructured":"Luan S, Sun L, Huang F (2010) MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Arch Med Res 41(2):67\u201374","journal-title":"Arch Med Res"},{"issue":"6","key":"1594_CR41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2796.2005.01570.x","volume":"258","author":"B Fadeel","year":"2005","unstructured":"Fadeel B, Orrenius S (2005) Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med 258(6):479\u2013517","journal-title":"J Intern Med"},{"issue":"1","key":"1594_CR42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s004410000193","volume":"301","author":"G H\u00e4cker","year":"2000","unstructured":"H\u00e4cker G (2000) The morphology of apoptosis. Cell Tissue Res 301(1):5\u201317","journal-title":"Cell Tissue Res"},{"issue":"22","key":"1594_CR43","doi-asserted-by":"crossref","first-page":"13703","DOI":"10.1074\/jbc.273.22.13703","volume":"273","author":"CM Simbulan-Rosenthal","year":"1998","unstructured":"Simbulan-Rosenthal CM, Rosenthal DS, Iyer S, Boulares AH, Smulson ME (1998) Transient poly (ADP-ribosyl) ation of nuclear proteins and role of poly (ADP-ribose) polymerase in the early stages of apoptosis. J Biol Chem 273(22):13703\u201313712","journal-title":"J Biol Chem"},{"key":"1594_CR44","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot087288","author":"LC Crowley","year":"2016","unstructured":"Crowley LC, Marfell BJ, Scott AP, Waterhouse NJ (2016) Quantitation of apoptosis and necrosis by annexin V binding, propidium iodide uptake, and flow cytometry. Cold Spring Harb Protoc. https:\/\/doi.org\/10.1101\/pdb.prot087288","journal-title":"Cold Spring Harb Protoc"},{"issue":"8","key":"1594_CR45","doi-asserted-by":"crossref","first-page":"e3022","DOI":"10.1038\/cddis.2017.396","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Lu J, Zhang Z, Zhu L, Dong S, Guo G, Li R, Nan Y, Yu K, Zhong Y (2017) Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines. Cell Death Dis 8(8):e3022","journal-title":"Cell Death Dis"},{"issue":"6","key":"1594_CR46","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.3892\/or.2015.4290","volume":"34","author":"J Miao","year":"2015","unstructured":"Miao J, Jiang Y, Wang D, Zhou J, Fan C, Jiao F, Liu B, Zhang J, Wang Y, Zhang Q (2015) Trichosanthin suppresses the proliferation of glioma cells by inhibiting LGR5 expression and the Wnt\/\u03b2-catenin signaling pathway. Oncol Rep 34(6):2845\u20132852","journal-title":"Oncol Rep"},{"issue":"12","key":"1594_CR47","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.bcp.2013.09.020","volume":"86","author":"S Aliwaini","year":"2013","unstructured":"Aliwaini S, Swarts AJ, Blanckenberg A, Mapolie S, Prince S (2013) A novel binuclear palladacycle complex inhibits melanoma growth in vitro and in vivo through apoptosis and autophagy. Biochem Pharmacol 86(12):1650\u20131663","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"1594_CR48","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrc2254","volume":"7","author":"R Mathew","year":"2007","unstructured":"Mathew R, Karantza-Wadsworth V, White E (2007) Role of autophagy in cancer. Nat Rev Cancer 7(12):961","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1594_CR49","first-page":"439","volume":"61","author":"S Paglin","year":"2001","unstructured":"Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, Domingo D, Yahalom J (2001) A Novel Response of Cancer Cells to Radiation Involves Autophagy and Formation of Acidic Vesicles. Cancer Res 61(2):439\u2013444","journal-title":"Cancer Res"},{"issue":"12","key":"1594_CR50","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.biocel.2004.05.009","volume":"36","author":"I Tanida","year":"2004","unstructured":"Tanida I, Ueno T, Kominami E (2004) LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 36(12):2503\u20132518","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"1594_CR51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1247\/csf.23.33","volume":"23","author":"A Yamamoto","year":"1998","unstructured":"Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y (1998) Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 23(1):33\u201342","journal-title":"Cell Struct Funct"},{"issue":"1","key":"1594_CR52","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3892\/or.2016.4782","volume":"36","author":"K Ma","year":"2016","unstructured":"Ma K, Zhang C, Huang M-Y, Li W-Y, Hu G-Q (2016) Cinobufagin induces autophagy-mediated cell death in human osteosarcoma U2OS cells through the ROS\/JNK\/p38 signaling pathway. Oncol Rep 36(1):90\u201398","journal-title":"Oncol Rep"},{"issue":"9","key":"1594_CR53","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/carcin\/bgt169","volume":"34","author":"SY Shin","year":"2013","unstructured":"Shin SY, Lee KS, Choi Y-K, Lim HJ, Lee HG, Lim Y, Lee YH (2013) The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt\/mTOR pathway in human U-87MG glioma cells. Carcinogenesis 34(9):2080\u20132089","journal-title":"Carcinogenesis"},{"issue":"3","key":"1594_CR54","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/nop\/npv041","volume":"3","author":"B Purow","year":"2016","unstructured":"Purow B (2016) Repurposing existing agents as adjunct therapies for glioblastoma. Neuro-Oncol Pract 3(3):154\u2013163. https:\/\/doi.org\/10.1093\/nop\/npv041","journal-title":"Neuro-Oncol Pract"},{"issue":"1","key":"1594_CR55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13046-017-0642-x","volume":"36","author":"C Abbruzzese","year":"2017","unstructured":"Abbruzzese C, Matteoni S, Signore M, Cardone L, Nath K, Glickson JD, Paggi MG (2017) Drug repurposing for the treatment of glioblastoma multiforme. J Exp Clin Cancer Res 36(1):169","journal-title":"J Exp Clin Cancer Res"},{"key":"1594_CR56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2018.04.039","volume":"428","author":"J Basso","year":"2018","unstructured":"Basso J, Miranda A, Sousa J, Pais A, Vitorino C (2018) Repurposing drugs for glioblastoma: from bench to bedside. Cancer Lett 428:173\u2013183","journal-title":"Cancer Lett"},{"key":"1594_CR57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fphar.2018.00218","volume":"9","author":"SK Tan","year":"2018","unstructured":"Tan SK, Jermakowicz A, Mookhtiar AK, Nemeroff CB, Sch\u00fcrer SC, Ayad NG (2018) Drug repositioning in glioblastoma: a pathway perspective. Front Pharmacol 9:218","journal-title":"Front Pharmacol"},{"key":"1594_CR58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2014.00123","volume":"5","author":"RT Kendall","year":"2014","unstructured":"Kendall RT, Feghali-Bostwick CA (2014) Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol 5:123","journal-title":"Front Pharmacol"},{"issue":"6","key":"1594_CR59","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ejca.2004.01.009","volume":"40","author":"H Fiebig","year":"2004","unstructured":"Fiebig H, Maier A, Burger A (2004) Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery. Eur J Cancer 40(6):802\u2013820","journal-title":"Eur J Cancer"},{"issue":"8","key":"1594_CR60","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2174\/1381612053381648","volume":"11","author":"A Pessina","year":"2005","unstructured":"Pessina A, Malerba I, Gribaldo L (2005) Hematotoxicity testing by cell clonogenic assay in drug development and preclinical trials. Curr Pharm Des 11(8):1055\u20131065","journal-title":"Curr Pharm Des"},{"issue":"6","key":"1594_CR61","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF00435836","volume":"23","author":"WN Hait","year":"1989","unstructured":"Hait WN, Morris S, Lazo JS, Figlin RJ, Durivage HJ, White K, Schwartz PE (1989) Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazine. Cancer Chemother Pharmacol 23(6):358\u2013362","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"1594_CR62","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00685030","volume":"31","author":"K Sridhar","year":"1993","unstructured":"Sridhar K, Krishan A, Samy T, Sauerteig A, Wellham L, McPhee G, Duncan R, Anac S, Ardalan B, Benedetto P (1993) Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studies. Cancer Chemother Pharmacol 31(6):423\u2013430","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"1594_CR63","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/cancers9060057","volume":"9","author":"L Annovazzi","year":"2017","unstructured":"Annovazzi L, Mellai M, Schiffer D (2017) Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma. Cancers 9(6):57","journal-title":"Cancers"},{"issue":"7015","key":"1594_CR64","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature03097","volume":"432","author":"MB Kastan","year":"2004","unstructured":"Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432(7015):316","journal-title":"Nature"},{"issue":"9","key":"1594_CR65","doi-asserted-by":"crossref","first-page":"a012716","DOI":"10.1101\/cshperspect.a012716","volume":"5","author":"A Mar\u00e9chal","year":"2013","unstructured":"Mar\u00e9chal A, Zou L (2013) DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol 5(9):a012716","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5569","key":"1594_CR66","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1126\/science.1069398","volume":"296","author":"A Celeste","year":"2002","unstructured":"Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E, Difilippantonio MJ (2002) Genomic instability in mice lacking histone H2AX. Science 296(5569):922\u2013927","journal-title":"Science"},{"issue":"3","key":"1594_CR67","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ncb945","volume":"5","author":"C Lukas","year":"2003","unstructured":"Lukas C, Falck J, Bartkova J, Bartek J, Lukas J (2003) Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nat Cell Biol 5(3):255","journal-title":"Nat Cell Biol"},{"issue":"46","key":"1594_CR68","doi-asserted-by":"crossref","first-page":"7691","DOI":"10.1038\/sj.onc.1207986","volume":"23","author":"G Buscemi","year":"2004","unstructured":"Buscemi G, Perego P, Carenini N, Nakanishi M, Chessa L, Chen J, Khanna K, Delia D (2004) Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks. Oncogene 23(46):7691","journal-title":"Oncogene"},{"issue":"3","key":"1594_CR69","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/carcin\/21.3.485","volume":"21","author":"SW Lowe","year":"2000","unstructured":"Lowe SW, Lin AW (2000) Apoptosis in cancer. Carcinogenesis 21(3):485\u2013495. https:\/\/doi.org\/10.1093\/carcin\/21.3.485","journal-title":"Carcinogenesis"},{"issue":"1","key":"1594_CR70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1568026053386872","volume":"5","author":"T Torigoe","year":"2005","unstructured":"Torigoe T, Izumi H, Ishiguchi H, Yoshida Y, Tanabe M, Yoshida T, Igarashi T, Niina I, Wakasugi T, Imaizumi T (2005) Cisplatin resistance and transcription factors. Curr Med Chem 5(1):15\u201327","journal-title":"Curr Med Chem"},{"issue":"1","key":"1594_CR71","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/cancers3011351","volume":"3","author":"A-M Florea","year":"2011","unstructured":"Florea A-M, B\u00fcsselberg D (2011) Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers 3(1):1351\u20131371","journal-title":"Cancers"},{"issue":"7","key":"1594_CR72","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0165-6147(02)02041-2","volume":"23","author":"PG Clarke","year":"2002","unstructured":"Clarke PG (2002) Apoptosis: from morphological types of cell death to interacting pathways. Trends Pharmacol Sci 23(7):308\u2013309","journal-title":"Trends Pharmacol Sci"},{"key":"1594_CR73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0070-2153(06)78006-1","volume":"78","author":"D Gozuacik","year":"2007","unstructured":"Gozuacik D, Kimchi A (2007) Autophagy and cell death. Curr Top Dev Biol 78:217\u2013245","journal-title":"Curr Top Dev Biol"},{"issue":"2","key":"1594_CR74","first-page":"129","volume":"1796","author":"R Laubenbacher","year":"2009","unstructured":"Laubenbacher R, Hower V, Jarrah A, Torti SV, Shulaev V, Mendes P, Torti FM, Akman S (2009) A systems biology view of cancer. Biochimica et Biophysica Acta BBA 1796(2):129\u2013139","journal-title":"Biochimica et Biophysica Acta BBA"},{"issue":"9","key":"1594_CR75","first-page":"2103","volume":"63","author":"T Kanzawa","year":"2003","unstructured":"Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I (2003) Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res 63(9):2103\u20132108","journal-title":"Cancer Res"},{"issue":"3","key":"1594_CR76","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.leukres.2006.06.021","volume":"31","author":"W Qian","year":"2007","unstructured":"Qian W, Liu J, Jin J, Ni W, Xu W (2007) Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. Leuk Res 31(3):329\u2013339","journal-title":"Leuk Res"},{"issue":"1","key":"1594_CR77","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12885-018-4504-5","volume":"18","author":"Y Fan","year":"2018","unstructured":"Fan Y, Chiu J-F, Liu J, Deng Y, Xu C, Zhang J, Li G (2018) Resveratrol induces autophagy-dependent apoptosis in HL-60 cells. BMC Cancer 18(1):581. https:\/\/doi.org\/10.1186\/s12885-018-4504-5","journal-title":"BMC Cancer"},{"issue":"6","key":"1594_CR78","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc3262","volume":"12","author":"E White","year":"2012","unstructured":"White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12(6):401","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"1594_CR79","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1101\/gad.287524.116","volume":"30","author":"R Amaravadi","year":"2016","unstructured":"Amaravadi R, Kimmelman AC, White E (2016) Recent insights into the function of autophagy in cancer. Genes Dev 30(17):1913\u20131930","journal-title":"Genes Dev"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-020-01594-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-020-01594-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-020-01594-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T09:50:03Z","timestamp":1722419403000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-020-01594-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,8]]},"references-count":79,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1594"],"URL":"https:\/\/doi.org\/10.1007\/s10495-020-01594-5","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,8]]},"assertion":[{"value":"8 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}